The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Metformin Use and Mortality in Ambulatory Patients With Diabetes and Heart Failure
Open accessAbstract
Background—: Despite the common coexistence of diabetes and heart failure (HF), the optimal medial treatment of diabetes in HF patients has not been well studied. We sought to compare the association between metformin use and clinical outcomes in a cohort of ambulatory patients with diabetes and established HF. Methods and Results—: Using propensity score–matched samples, we examined the association between metformin use and the risk of death or risk of hospitalization in a national cohort of 6185 patients with HF and diabetes treated in ambulatory clinics at Veteran Affairs medical centers. In this cohort, 1561 (25.2%) patients were treated with metformin. At 2 years of follow-up, death occurred in 246 (15.8%) patients receiving metformin and in 1177 (25.5%) patients not receiving metformin ( P <0.001). In the propensity score–matched analysis (n=2874), death occurred in 232 (16.1%) patients receiving metformin compared with 285 (19.8%) patients not receiving metformin (hazard ratio, 0.76; 95% confidence interval, 0.63 to 0.92; P <0.01). In propensity score–matched analyses, HF hospitalization or total hospitalization rates were not significantly different between individuals treated with metformin compared with those not treated with metformin (hazard ratio, 0.93; 95% confidence interval, 0.74 to 1.18; and hazard ratio, 0.94; 95% confidence interval, 0.83 to 1.07, respectively). Conclusions—: Metformin therapy was associated with lower rates of mortality in ambulatory patients with diabetes and HF. Future prospective studies are necessary to define the optimal therapy for diabetic patients with HF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Austin, P. C. (2009) · Statistics in Medicine · doi:10.1002/sim.3697 · Cited by 6,758
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
MacDonald, M. R., Petrie, M. C., Varyani, F., Ostergren, J., Michelson, E. L., Young, J. B., Solomon, S. D., Granger, C. B., Swedberg, K., Yusuf, S., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn153 · Cited by 694
Masoudi, F. A., Inzucchi, S. E., Wang, Y., Havranek, E. P., Foody, J. M., & Krumholz, H. M. (2005) · Circulation · doi:10.1161/01.cir.0000154542.13412.b1 · Cited by 458
Kooy, A., de Jager, J., Lehert, P., Bets, D., Wulffelé, M. G., Donker, A. J. M., & Stehouwer, C. D. A. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.20 · Cited by 440 · cited 1×
“These potential mechanisms may have contributed to the reduction in macrovascular events observed in a subset of overweight patients treated with metformin in the United Kingdom Prospective Diabetes Study (UKPDS) 34(20) and in a recent study of patients with type 2 diabetes in which metformin was added to a background…”
Improved clinical outcomes associated with metformin in patients with diabetes and heart failure
Eurich, D. T., Majumdar, S. R., McAlister, F. A., Tsuyuki, R. T., & Johnson, J. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2345 · Cited by 419 · cited 2×
“16 In the study of new users of oral diabetic therapy, propensity score regression analyses were performed, but the study lacked important potential confounding variables such as renal function, left ventricular function, and glycemic control.(9) Our study extends the previous literature by using propensity-score matc…”
Diabetes in heart failure: prevalence and impact on outcome in the population
From, A. M., Leibson, C. L., Bursi, F., Redfield, M. M., Weston, S. A., Jacobsen, S. J., Rodeheffer, R. J., & Roger, V. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.05.024 · Cited by 295 · cited 1×
“In a recent community based survey in Olmstead County, investigators determined that 20% of individuals presenting with a first episode of HF had a prior diagnosis of diabetes.(1) In addition, the investigators demonstrated that prevalence of diabetes in patients with HF had increased markedly over a 20-year period (3.”
Research works printed but not linked: 17
- 10.1016/j.ahj.2004.08.005 · DOI · Paper page
- 10.1161/01.cir.0000142047.28024.f2 · DOI · Paper page
- 10.1136/bmj.39314.620174.80 · DOI · Paper page
- 10.1056/NEJM199801223380415 · DOI · Paper page
- 10.2337/dc07-1686 · DOI · Paper page
- 10.1186/1745-6215-10-12 · DOI
- 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B · doi:10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b
- 10.1056/NEJMsa021899 · DOI · Paper page
- 10.1016/j.ahj.2005.12.004 · DOI
- 10.7326/0003-4819-145-4-200608150-00004 · DOI · Paper page
- 10.7326/0003-4819-87-5-591 · DOI
- 10.2337/diacare.27.7.1791 · DOI · Paper page
- 10.1001/archinte.163.21.2594 · DOI · Paper page
- 10.1016/S0140-6736(98)07037-8 · DOI · Paper page
- Verma S, McNeill JH. Metformin improves cardiac function in isolated streptozotocin-diabetic rat hearts. Am J Physiol. 1994;266:H714–H719.
- 10.1161/circresaha.108.190918 · DOI · Paper page
- 10.1161/circulationaha.108.798561 · DOI · Paper page
Cited by
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Cardiac Metabolism in Heart Failure: Implications Beyond ATP Production
Doenst, T., Nguyen, T. D., & Abel, E. D. (2013) · Circulation Research · doi:10.1161/circresaha.113.300376 · Cited by 1,111
Zannad, F., Cannon, C. P., Cushman, W. C., Bakris, G. L., Menon, V., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., Wilson, C., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62225-x · Cited by 757
Kenny, H. C., & Abel, E. D. (2019) · Circulation Research · doi:10.1161/circresaha.118.311371 · Cited by 660
Metadata
- Authors
- Aguilar, D., Chan, W., Bozkurt, B., Ramasubbu, K., & Deswal, A.
- Venue
- Circulation: Heart Failure
- Published
- 2011-01
- Volume
- 4
- Issue
- 1
- Pages
- 53-58
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2049022861
- Cited by
- 203
- References
- 7
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metformin Use and Mortality in Ambulatory Patients With Diabetes and Heart Failure. https://app.cochat.ai/papers/10.1161/circheartfailure.110.952556
- The paper
- Aguilar, D., Chan, W., Bozkurt, B., Ramasubbu, K., & Deswal, A. (2011). Metformin Use and Mortality in Ambulatory Patients With Diabetes and Heart Failure. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.110.952556
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.